The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 26, issue 3, 2025

Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19 pp. 337-351

Wenjing Zhou, Yaqin Li, Jan Busschbach, Michael Herdman, Zhihao Yang and Yanming Lu

The formal care costs of dementia: a longitudinal study using Swedish register data pp. 353-361

Jennifer Zilling, Ulf-G. Gerdtham, Johan Jarl, Sanjib Saha and Sofie Persson

A critical review of the use of R2 in risk equalization research pp. 363-375

Wynand P. M. M. Ven and Richard C. Kleef

Time value of informal care of people with alzheimer’s disease in Spain: a population-based analysis pp. 377-402

Vilaplana-Prieto C and Oliva-Moreno J

Testing four cognition bolt-on items to the EQ-5D in a general Chinese population pp. 403-411

Meixia Liao, Hongyan Wu, Zhihao Yang, Yan Huang, Mathieu F. Janssen, Gouke Bonsel and Nan Luo

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens pp. 413-425

Sara W. Quist, Sophie te Dorsthorst, Roel D. Freriks, Maarten J. Postma, Carel B. Hoyng and Freekje Asten

Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial pp. 427-454

Paddy Gillespie, Frank Moriarty, Susan M. Smith, Anna Hobbins, Sharon Walsh, Barbara Clyne, Fiona Boland, Tara McEnteggart, Michelle Flood, Emma Wallace and Caroline McCarthy

Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade pp. 455-471

Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Postma, Cornelis Boersma, Job Frank Martien Boven and Maarten Jacobus Postma

The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease pp. 473-485

M. Mercédesz Angyal, Mathieu F. Janssen, Péter L. Lakatos, Valentin Brodszky and Fanni Rencz

Valuation of the EQ-5D-3L in Jordan pp. 487-501

Abeer Rabayah, Bram Roudijk, Fredrick Dermawan Purba, Fanni Rencz, Saad Jaddoua and Uwe Siebert

Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis pp. 503-512

Michael Abbott, Mandy Ryan, Rodolfo Hernández, Lynda McKenzie, Sebastian Heidenreich, Lynne Hocking, Caroline Clark, Morad Ansari, David Moore, Anne Lampe, Ruth McGowan, Jonathan Berg and Zosia Miedzybrodzka

An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries pp. 513-536

Giovanny Leon, Christophe Carbonel, Aparajit Rampuria, Ravindra Singh Rajpoot, Parth Joshi and Panos Kanavos

Volume 26, issue 2, 2025

Setting incentives right with long-term risk adjustment pp. 147-151

Simon Reif, Sabrina Schubert and Achim Wambach

Long-term returns to local health-care spending pp. 153-182

Jakub Červený and Jan C. van Ours

Monetary value of health—a practical decision-making framework combining equity considerations and WTP pp. 183-198

Elizabeta Ribarić, Ismar Velić and Ana Bobinac

Workload and short sickness absences in a cohort of Finnish hospital employees pp. 199-222

Tero Kuusi, Martti Kulvik, Mikko Härmä and Annina Ropponen

Population normative data for OxCAP-MH capability scores pp. 223-231

Péter György Balázs, Agata Łaszewska, Judit Simon and Valentin Brodszky

Does medial tourism promote growth in healthcare sector? pp. 233-241

Hassan Gholipour Fereidouni and Kourosh Esfandiar

The hidden cost of sophistication: economic complexity and obesity pp. 243-265

Ronald Djeunankan, Sosson Tadadjeu, Henri Njangang and Ummad Mazhar

A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial pp. 267-273

Etienne Minvielle, Henri Leleu, Marc Masseti, Arlindo Ferreira, Gérard Pouvourville, Mario Di Palma and Florian Scotté

The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol pp. 275-297

Henry Bailey, Bram Roudijk and Ricky Brathwaite

Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico pp. 299-311

Omar Galárraga, Marta Wilson-Barthes, Carlos Chivardi, Nathalie Gras-Allain, Fernando Alarid-Escudero, Monica Gandhi, Kenneth H. Mayer and Don Operario

Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP) pp. 313-323

Thomas Grochtdreis, Hans-Helmut König and Judith Dams

Economies of scope in the Norwegian public hospital sector pp. 325-335

Nils Arne Lindaas, Kjartan Sarheim Anthun, Sverre Kittelsen and Jon Magnussen

Volume 26, issue 1, 2025

Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease? pp. 1-5

Livio Garattini and Giovanni Fattore

The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events pp. 7-21

Cate Bailey, Kim Dalziel, Leanne Constable, Nancy J. Devlin, Harriet Hiscock, Helen Skouteris and Tessa Peasgood

Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial pp. 23-34

Ansam Barakat, Jurgen E. Cornelis, Jack J. M. Dekker, Nick M. Lommerse, Aartjan T. F. Beekman and Matthijs Blankers

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden pp. 35-48

Thomas Sejersen, Sophie Graham, Anne-Berit Ekström, Anna-Karin Kroksmark, Marta Kwiatkowska, Michael L. Ganz, Nahila Justo, Karl Gertow and Alex Simpson

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system pp. 49-62

Silvia Fenix-Caballero, Adrián Sanchez-Vegas, Emilio Jesús Alegre Del-Rey, David Epstein, Leticia Garcia-Mochon and Antonio Olry de Labry Lima

Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation pp. 63-70

Clara Mukuria, Matthew Franklin and Sebastian Hinde

The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries pp. 71-85

Hamraz Mokri, Pieter Baal and Maureen Rutten- van Mölken

Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes pp. 87-93

Maiken Skovrider Aaskoven, Trine Kjær and Dorte Gyrd-Hansen

Do institutions matter for citizens’ health status? Empirical evidence from Italy pp. 95-115

M. Alessandra Antonelli and Giorgia Marini

Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO) pp. 117-128

Sophie Gottschalk, Hans-Helmut König, Andrea Weber, Michael F. Leitzmann, Michael J. Stein, Annette Peters, Claudia Flexeder, Lilian Krist, Stefan N. Willich, Katharina Nimptsch, Tobias Pischon, Sylvia Gastell, Karen Steindorf, Florian Herbolsheimer, Nina Ebert, Karin B. Michels, Anja Dorrn, Volker Harth, Nadia Obi, André Karch, Henning Teismann, Henry Völzke, Claudia Meinke-Franze, Leon Klimeck, Teresa L. Seum and Judith Dams

Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care pp. 129-139

Giulio Cisco, Armando N. Meier, Nicolas Senn, Yolanda Mueller, Andreas Kronenberg, Isabella Locatelli, José Knüsli, Loïc Lhopitallier, Noemie Boillat-Blanco and Joachim Marti

Letter to the Editor: Lazzaro responds to Kennedy et al pp. 141-142

Carlo Lazzaro

Correction: AOTMiT reimbursement recommendations compared to other HTA agencies pp. 143-146

Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski and Maciej Niewada

Volume 25, issue 9, 2024

Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China pp. 1471-1484

Aixue Zhang, Jing Li, Zhuxin Mao, Zitong Wang, Jing Wu, Nan Luo, Peng Liu and Pei Wang

What remains after the money ends? Evidence on whether admission reductions continued following the largest health and social care integration programme in England pp. 1485-1504

Vasudha Wattal, Katherine Checkland, Matt Sutton and Marcello Morciano

Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease pp. 1505-1515

Richard Huan Xu, Nan Luo and Dong Dong

The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data pp. 1517-1527

Jolien Cremers, Torben Heien Nielsen and Claus Thorn Ekstrøm

Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study pp. 1529-1537

Timothée Lehut, Céline Lambert, Romain Mortier, Emmanuel Futier, Russell Chabanne, Ulrich Bauer, Philippe Verdier, Ramin Ravan, Philippe Ocquidant, Charline Mourgues and Alexandre Lautrette

The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands pp. 1539-1555

Micha J. Pilz, Simon Seyringer, Lára R. Hallsson, Andrew Bottomley, Femke Jansen, Madeleine T. King, Richard Norman, Marianne J. Rutten, Irma M. Verdonck- de Leeuw, Peter D. Siersema and Eva Maria Gamper

Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands pp. 1557-1567

Simon Pol, Maarten J. Postma and Cornelis Boersma

Economic value of diastasis repair with the use of mesh compared to no intervention in Italy pp. 1569-1580

Carla Rognoni, Alessandro Carrara, Micaela Piccoli, Vincenzo Trapani, Nereo Vettoretto, Giorgio Soliani and Rosanna Tarricone

From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands pp. 1581-1594

Iris Meulman, Ellen Uiters, Mariëlle Cloin, Jeroen Struijs, Johan Polder and Niek Stadhouders

Costs attributable to hypercholesterolemia in a single period and over the life cycle pp. 1595-1603

Stephanie Reitzinger, Miriam Reiss and Thomas Czypionka

Poverty, work intensity, and disability: evidence from European countries pp. 1605-1624

Chiara Mussida and Dario Sciulli

Comparing GPs according to their model of practice: are multiprofessional group practices associated with more favourable working conditions? pp. 1625-1640

Myriam Biais, Matthieu Cassou and Carine Franc

Volume 25, issue 8, 2024

AOTMiT reimbursement recommendations compared to other HTA agencies pp. 1291-1310

Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski and Maciej Niewada

The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands pp. 1311-1331

Saif Elayan, Viola Angelini, Erik Buskens and Alice Boer

A Spanish value set for the SF-6D based on the SF-12 v1 pp. 1333-1343

Jorge-Eduardo Martínez-Pérez, José-María Abellán-Perpiñán, Fernando-Ignacio Sánchez-Martínez and Juan-José Ruiz-López

Comparing heuristic valuation processes between health state valuation from child and adult perspectives pp. 1345-1360

Stefan A. Lipman and Vivian T. Reckers-Droog

Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers pp. 1361-1370

Wenjing Zhou, Anle Shen, Zhihao Yang, Pei Wang, Bin Wu, Michael Herdman, Jan Busschbach and Nan Luo

Unravelling risk selection in Spanish general government employee mutual funds: evidence from cancer hospitalizations in the public health network pp. 1371-1381

Jaime Pinilla, Beatriz G. López-Valcárcel and Enrique Bernal-Delgado

Measuring EQ-5D-5L utility values in parents who have experienced perinatal death pp. 1383-1391

Elizabeth M. Camacho, Katherine J. Gold, Margaret Murphy, Claire Storey and Alexander E. P. Heazell

A principled approach to non-discrimination in cost-effectiveness pp. 1393-1416

Darius Lakdawalla and Jason N. Doctor

Systematic methodological review of health state values in glaucoma cost-utility analyses pp. 1417-1435

Kevin Kennedy, Gurkaran Sarohia, Dominik Podbielski, Simon Pickard, Jean-Eric Tarride and Feng Xie

Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD) pp. 1437-1448

Louis S. Matza, Katie D. Stewart, Marie Fournier, Donna Rowen, Robin Lachmann, Maurizio Scarpa, Eugen Mengel, Travis Obermeyer, Evren Ayik, Fernando Laredo and Ruth Pulikottil-Jacob

The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands pp. 1449-1459

Vivian Reckers-Droog, Joost Enzing and Werner Brouwer

Preference-based utility weights for the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), with a focus on non-dystrophic myotonia (NDM) pp. 1461-1469

Andrew Lloyd, Kim Rand, Cleo Pike and Crispin Ellis

Volume 25, issue 7, 2024

Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states pp. 1087-1094

Zhihao Yang, Kim Rand, Elly Stolk, Jan Busschbach and Nan Luo

Impact of Long COVID on productivity and informal caregiving pp. 1095-1115

Joseph Kwon, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Jordan Mullard, Ghazala Mir, Brendan Delaney, Manoj Sivan and Stavros Petrou

Risk adjustment for regional healthcare funding allocations with ensemble methods: an empirical study and interpretation pp. 1117-1131

Tuukka Holster, Shaoxiong Ji and Pekka Marttinen

Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK pp. 1133-1146

J. P. Sevilla, Daniel Tortorice, David Kantor, John Regan, Kinga H. Meszaros, Ekkehard C. Beck, Najida Begum and David E. Bloom

The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands pp. 1147-1163

Ghyli Kirshner, Peter Makai, Chiara Brouns, Lonneke Timmers and Ron Kemp

Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people pp. 1165-1176

Tracey H. Sach, Mary Onoja, Holly Clarke, Miriam Santer, Ingrid Muller, Taeko Becque, Beth Stuart, Julie Hooper, Mary Steele, Sylvia Wilczynska, Matthew J. Ridd, Amanda Roberts, Amina Ahmed, Lucy Yardley, Paul Little, Kate Greenwell, Katy Sivyer, Jacqui Nuttall, Gareth Griffiths, Sandra Lawton, Sinéad M. Langan, Laura Howells, Paul Leighton, Hywel C. Williams and Kim S. Thomas

Looking inside the lab: a systematic literature review of economic experiments in health service provision pp. 1177-1204

Massimo Finocchiaro Castro, Calogero Guccio and Domenica Romeo

A state-level analysis of macro-level factors associated with hospital readmissions pp. 1205-1215

Reginald A. Silver, Joumana Haidar and Chandrika Johnson

Can redistribution of vaccine improve global welfare? Lessons from COVID-19 pp. 1217-1238

Gunjan Kumari and Oindrila Dey

On spillovers in economic evaluations: definition, mapping review and research agenda pp. 1239-1260

María J. Mendoza-Jiménez, Job Exel and Werner Brouwer

Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis pp. 1261-1273

Andrea Marcellusi, Francesco Saverio Mennini, Massimo Andreoni and Loreta A. Kondili

Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions pp. 1275-1289

Susanna Sten-Gahmberg, Kine Pedersen, Ingrid Gaarder Harsheim, Hanna Isabel Løyland, Øyvind Snilsberg, Tor Iversen, Geir Godager, Erik Magnus Sæther and Birgit Abelsen

Volume 25, issue 6, 2024

Valuation of EQ-5D-5L health states from cancer patients’ perspective: a feasibility study pp. 915-924

Qingqing Chai, Zhihao Yang, Xiaoyan Liu, Di An, Jiangyang Du, Xiumei Ma, Kim Rand, Bin Wu and Nan Luo

The economic burden of mental disorders: results from the Netherlands mental health survey and incidence study-2 pp. 925-934

B. F. M. Wijnen, M. Have, R. Graaf, H. J. Hoek, J. Lokkerbol and Filip Smit

How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe pp. 935-950

Anna-Maria Fontrier, Bregtje Kamphuis and Panos Kanavos

New evidence on supplier-induced demand in China’s public tertiary hospitals: is the cost of hospitalization higher in the off-season? pp. 951-962

Chi Shen, Qiwei Deng, Sha Lai, Liu Yang, Dantong Zhao, Yaxin Zhao and Zhongliang Zhou

Healthcare information management and operational cost performance: empirical evidence pp. 963-977

Amit S. Malhan, Kiarash Sadeghi-R, Robert Pavur and Lou Pelton

Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy pp. 979-997

Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Tobias Boch and Julia Caroline Michaeli

Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders pp. 999-1011

Mario Cesare Nurchis, Francesca Clementina Radio, Luca Salmasi, Aurora Heidar Alizadeh, Gian Marco Raspolini, Gerardo Altamura, Marco Tartaglia, Bruno Dallapiccola and Gianfranco Damiani

Country-level effects of diagnosis-related groups: evidence from Germany’s comprehensive reform of hospital payments pp. 1013-1030

Robert Messerle and Jonas Schreyögg

Patient-reported experience is associated with higher future revenue and lower costs of hospitals pp. 1031-1039

Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann and Michael M. Havranek

Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication pp. 1041-1055

Jen-Yu Amy Chang, Chien-Ning Hsu, Juan Manuel Ramos-Goñi, Nan Luo, Hsiang-Wen Lin and Fang-Ju Lin

Projected costs of informal care for older people in England pp. 1057-1070

Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal and Raphael Wittenberg

The elicitation of patient and physician preferences for calculating consumer-based composite measures on hospital report cards: results of two discrete choice experiments pp. 1071-1085

Martin Emmert, Stefan Rohrbacher, Florian Meier, Laura Heppe, Cordula Drach, Anja Schindler, Uwe Sander, Christiane Patzelt, Cornelia Frömke, Oliver Schöffski and Michael Lauerer

Volume 25, issue 5, 2024

Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers pp. 731-741

Katalin Gaspar, Ramsis Croes, Misja Mikkers and Xander Koolman

The impacts of working from home on individual health and well-being pp. 743-762

Manuel Denzer and Philipp Grunau

Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis pp. 763-774

Lorna Wills, Diana Nagarwalla, Clare Pearson, Sean McPhail, Rose Hinchliffe, Ben Sharpless, Fahmina Fardus-Reid, Lyndsy Ambler, Samantha Harrison and Jon Shelton

Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer pp. 775-785

Szu-Chun Yang, Wu-Wei Lai, Tzu-I. Wu, Jing-Shiang Hwang, Jung- Der Wang and Fuhmei Wang

Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec pp. 787-811

Christian R. C. Kouakou, Jie He and Thomas G. Poder

How do family doctors respond to reduced waiting times for cancer diagnosis in secondary care? pp. 813-828

Helen Hayes, Rachel Meacock, Jonathan Stokes and Matt Sutton

A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe pp. 829-844

Li Sun, Shruti Patel, Camilla Fiorina, Audrey Glass, Lise Rochaix, Anna M. Foss and Rosa Legood

Assessing the relation between financial performance and long-term bank loan interest rates for healthcare providers in the Netherlands: a panel data analysis pp. 845-855

Erik Wackers, Rick Smit, Niek Stadhouders and Patrick Jeurissen

Pay-for-Performance incentives for specialised services in England: a mixed methods evaluation pp. 857-876

Yan Feng, Søren Rud Kristensen, Paula Lorgelly, Rachel Meacock, Alberto Núñez, Marina Rodés-Sánchez, Luigi Siciliani and Matt Sutton

Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose pp. 877-888

Maria Katharina Schweitzer, Manuel Nico Dold, Astrid Genet, Klaus Gossens, Thomas Klein-Hessling, Nils Löffler, Matthias Rabel, Andrej Rasch, Eva-Maria Reuter, Jessica Schmelcher, Natalia Wolfram and Sebastian Werner

The EORTC QLU-C10D: the Hong Kong valuation study pp. 889-901

Richard Huan Xu, Eliza Lai-yi Wong, Nan Luo, Richard Norman, Jens Lehmann, Bernhard Holzner, Madeleine T. King and Georg Kemmler

Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment pp. 903-913

Saskia Schawo, Renske Hoefman, Vivian Reckers-Droog, Liesbet Lawerman- van de Wetering, Yifrah Kaminer, Werner Brouwer and Leona Hakkaart- van Roijen

Volume 25, issue 4, 2024

Psychometric properties and general population reference values for PROMIS Global Health in Hungary pp. 549-562

Alex Bató, Valentin Brodszky, Ariel Zoltán Mitev, Balázs Jenei and Fanni Rencz

Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic pp. 563-578

Sebastian Himmler, Job Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Barros and Aleksandra Torbica

Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study pp. 579-600

Vivienne Hillerich, Frederik Valbert, Silke Neusser, Oliver Pfaar, Ludger Klimek, Annette Sperl, Thomas Werfel, Eckard Hamelmann, Cordula Riederer, Stefanie Wobbe-Ribinski, Anja Neumann, Jürgen Wasem and Janine Biermann-Stallwitz

The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off pp. 601-613

Zhongyu Lang, Arthur Attema and Stefan A. Lipman

The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial pp. 615-629

Dirk Heider, Farhad Rezvani, Herbert Matschinger, Jörg Dirmaier, Martin Härter, Lutz Herbarth, Patrick Steinisch, Hannes Böbinger, Franziska Schuhmann, Gundula Krack, Thomas Korth, Lara Thomsen, Daniela Patricia Chase, Robert Schreiber, Mark-Dominik Alscher, Benjamin Finger and Hans-Helmut König

Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling pp. 631-639

Nicolas Boespflug, Jérôme Wittwer and Antoine Bénard

Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma pp. 641-653

Jean-Baptiste Trouiller, Georgios F. Nikolaidis, Bérengère Macabeo, Nicolas Meyer, Laetitia Gerlier, Max Schlueter and Philippe Laramee

Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK pp. 655-669

Chelsea Chunwen Xiao, Nikita Makarchev and Xin Tao

Disclosing the ‘Big C’: what does cancer survivorship signal to employers? pp. 671-688

Philippe Sterkens, Adelina Sharipova and Stijn Baert

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland pp. 689-699

Jeroen H. J. Paulissen, Ahmed H. Seddik, Kyle J. Dunton, Christopher J. Livings, Marinus Hulst, Maarten J. Postma, Lisa A. Jong and Roel D. Freriks

Immigrant assimilation in health care utilisation in Spain pp. 701-715

Zuleika Ferre, Patricia Triunfo and José Ignacio Antón

Using machine learning to estimate health spillover effects pp. 717-730

Bruno Wichmann and Roberta Moreira Wichmann

Volume 25, issue 3, 2024

Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada pp. 363-377

Michael Hong, Rose Anne Devlin, Gregory S. Zaric, Amardeep Thind and Sisira Sarma

Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulation pp. 379-396

Michel Oskam, Richard C. van Kleef and Rudy Douven

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis pp. 397-409

Michael Situ, Ute I. Schwarz, Guangyong Zou, Eric McArthur, Richard B. Kim, Amit X. Garg and Sisira Sarma

A cost-of-illness study of Behçet syndrome in Italy pp. 411-422

Valentina Lorenzoni, Diana Marinello, Ilaria Palla, Marta Mosca, Giuseppe Turchetti and Rosaria Talarico

Self-interest, positional concerns and distributional considerations in healthcare preferences pp. 423-446

Aemiro Melkamu Daniel, Job Exel and Caspar G. Chorus

Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial pp. 447-457

Didier Tchétché, Coline Dubois Gennes, Quentin Cormerais, Benjamin P. Geisler, Camille Dutot, Fanny Wilquin-Bequet, Manon Breau-Brunel, Béranger Lueza and Jan B. Pietzsch

Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan pp. 459-470

Munenobu Kashiwa

Analyzing nurses’ decisions to leave their profession—a duration analysis pp. 471-496

Martin Kroczek

Informal care at old age at home and in nursing homes: determinants and economic value pp. 497-511

Quitterie Roquebert and Marianne Tenand

Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France pp. 513-523

Daniel Bejarano-Quisoboni, Henri Panjo, Brice Fresneau, Chiraz El‑Fayech, François Doz, Aurore Surun, Florent Vathaire and Nathalie Pelletier-Fleury

The link between physician motivation and care pp. 525-537

Anne Sophie Oxholm, Dorte Gyrd-Hansen, Christian Bøtcher Jacobsen, Ulrich Thy Jensen and Line Bjørnskov Pedersen

Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease pp. 539-548

Isa Maria Steiner, Bernd Bokemeyer and Tom Stargardt

Volume 25, issue 2, 2024

Modeling European health systems: an ideal chain of services pp. 189-192

Livio Garattini and Marco Badinella Martini

The causal effect of catastrophic health expenditure on poverty in Poland pp. 193-206

Aleksandra Kolasa and Ewa Weychert

Nonprofit behavior altered by monetary donations: evidence from the U.S. hospice industry pp. 207-220

Miao Guo, Lei Guo and Yang Li

Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program pp. 221-236

Saeed Piri

Alcohol prices, the April effect, and the environment, in violence-related injury in England and Wales pp. 237-255

Kent Matthews, Saeed Heravi, Peter Morgan, Nicholas Page, Jonathan Shepherd and Vaseekaran Sivarajasingam

Analysis of oncological drugs authorised in Spain in the last decade: association between clinical benefit and reimbursement pp. 257-267

P. Nieto-Gómez, C. Castaño-Amores, A. Rodríguez-Delgado and R. Álvarez-Sánchez

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort pp. 269-279

Isabella Vanorio-Vega, Panayotis Constantinou, Victor Bret, Stéphanie Gentile, Patrik Finne, Bénédicte Sautenet, Philippe Tuppin and Cécile Couchoud

Health impact of borders: general reflections and a case study from the Polish–German border pp. 281-292

Julia Kuntosch, Marie-Luise Ruebsam, Jakub Orsson, Dorota Orsson, Klaus Hahnenkamp, Jörg Hartleib and Steffen Flessa

Referring physicians' intention to use hospital report cards for hospital referral purposes in the presence or absence of patient-reported outcomes: a randomized trial pp. 293-305

Martin Emmert, Anja Schindler, Laura Heppe, Uwe Sander, Christiane Patzelt, Michael Lauerer, Eckhard Nagel, Cornelia Frömke, Oliver Schöffski and Cordula Drach

Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma pp. 307-317

Béranger Lueza, Anne Aupérin, Charlotte Rigaud, Thomas G. Gross, Marta Pillon, Rafael F. Delgado, Anne Uyttebroeck, G. A. Amos Burke, József Zsíros, Monika Csóka, Mathieu Simonin, Catherine Patte, Véronique Minard-Colin and Julia Bonastre

Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study pp. 319-332

Elizabeth M. Camacho, Gemma E. Shields, Carolyn A. Chew-Graham, Emily Eisner, Simon Gilbody, Elizabeth Littlewood, Dean McMillan, Kylie Watson, Pasco Fearon and Deborah J. Sharp

Education and medication use later in life and the role of intelligence pp. 333-361

Gianmaria Niccodemi and Govert Bijwaard

Volume 25, issue 1, 2024

Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality pp. 1-5

Maurizio Capuozzo, Venere Celotto, Andrea Zovi, Roberto Langella and Francesco Ferrara

Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population pp. 7-19

Shitong Xie, Jing Wu and Gang Chen

Health-related quality of life assessed by EQ-5D-5L and its determinants among rural adults: result from the Henan rural cohort study pp. 21-30

Shengxiang Sang, Wei Liao, Ning Kang, Xueyan Wu, Ze Hu, Xiaotian Liu, Hongjian Zhang and Chongjian Wang

The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions pp. 31-47

Alvaro Almeida

The role of education in health policy reform outcomes: evidence from Japan pp. 49-76

Masato Oikawa

Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data pp. 77-89

Boniface Oyugi, Olena Nizalova, Sally Kendall and Stephen Peckham

Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France pp. 91-101

Julien Bergeot and Florence Jusot

Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy pp. 103-115

Richard Huan Xu, Yi Dai, Shamay S. M. Ng, Hector W. H. Tsang, Shuyang Zhang and Dong Dong

COVID-19 and EQ-5D-5L health state valuation pp. 117-145

Edward J. D. Webb, Paul Kind, David Meads and Adam Martin

Canada population norms for the EQ-5D-5L pp. 147-155

Jiajun Yan, Shitong Xie, Jeffrey A. Johnson, Eleanor Pullenayegum, Arto Ohinmaa, Stirling Bryan and Feng Xie

Short- and intermediate-term impact of DTC telemedicine consultations on subsequent healthcare consumption pp. 157-176

Cecilia Dahlgren, Emma Spånberg, Sofia Sveréus, Margareta Dackehag, Per Wändell and Clas Rehnberg

Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden pp. 177-185

Maria Silfverschiöld, Kristin Carlwig, Johan Jarl, Lennart Greiff, Per Nilsson, Johan Wennerberg, Björn Zackrisson, Ellinor Östensson and Johanna Sjövall

Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic pp. 187-187

Sebastian Himmler, Job Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Barros and Aleksandra Torbica